EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Long‐Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc ‐Conjugated siRNAs

Gijs-Jan Scholten iD, Clara Grundmann, Åsa Nordling, Caroline Coskun, Volker Engelhardt, Lingheswar Sadhasivam iD, Tomaž Einfalt, Magnus Ingelman-Sundberg, Sander van Riet

Clinical and Translational Science · 2026

DOI: 10.1111/cts.70536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2026. Verfasst von Gijs-Jan Scholten und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: RNA, Small Interfering, Liver, Acetylgalactosamine, Spheroids, Cellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in RNA interference technology have established it as a powerful therapeutic tool with important future potential. The design and the chemical modifications of the siRNA nucleotide backbone have greatly enhanced stability, durability, and pharmacokinetics while minimizing tolerability risks. The optimal combination of these modifications depends on the target gene, tissue, and RNA sequence, necessitating an iterative, experimental approach that currently relies heavily on animal models. To reduce the reliance and number of (humanized) animals required, we developed a human long‐term liver 3D spheroid model designed for screening GalNAc‐conjugated siRNAs which captures the process of uptake, potency, and durability for early in vitro screening. These liver spheroids remain viable in culture for at least 5 weeks while maintaining expression of the asialoglycoprotein receptor to facilitate GalNAc mediated uptake. siRNA was efficiently internalized by the spheroids without the need for transfection reagents, and its durable silencing efficiency was assessed by monitoring AHSA1 target gene expression over time. Target gene silencing in the spheroid model persisted up to 5 weeks post‐treatment. Fluorescently labeled siRNA enabled visualization of uptake and distribution within the spheroid, revealing somewhat reduced siRNA accumulation in pericentral CYP3A4+ hepatocytes accompanied with somewhat reduced ASGR1 expression. No signs of hepatotoxicity were observed under the conditions used. By varying the number of phosphorothioate modifications in the siRNA backbone, distinct differences in silencing efficiency and durability were observed which were principally similar as obtained in vivo in mice. We propose that this long‐term human liver spheroid model provides a valuable preclinical platform for evaluating siRNA‐based therapeutics with respect to uptake, durability, and silencing efficiency, and could refine early in vitro screening and accelerate drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingLiverAcetylgalactosamineSpheroids, CellularRNA InterferenceHumansAsialoglycoprotein ReceptorGene SilencingHepatocytesAnimals

Stichwörter der Autor:innen

asialoglycoprotein receptorliver spheroidssiRNA stabilitysilencing efficiency

Substanzen

RNA, Small InterferingAcetylgalactosamineAsialoglycoprotein ReceptorASGR1 protein, human

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • NOVARTIS Pharma AG, Basel, Switzerland.

ORCID-Profile: Gijs-Jan Scholten, Lingheswar Sadhasivam

Zitieren

APA

Scholten, G. J., Grundmann, C., Nordling, Å., Coskun, C., Engelhardt, V., Sadhasivam, L., Einfalt, T., Ingelman-Sundberg, M., & van Riet, S. (2026). A Long‐Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc ‐Conjugated siRNAs. Clinical and Translational Science. https://doi.org/10.1111/cts.70536

Vancouver

Scholten GJ, Grundmann C, Nordling Å, Coskun C, Engelhardt V, Sadhasivam L, et al. A Long‐Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc ‐Conjugated siRNAs. Clinical and Translational Science. 2026. doi:10.1111/cts.70536

BibTeX
@article{Scholten2026,
  author = {Scholten, Gijs-Jan and Grundmann, Clara and Nordling, Åsa and Coskun, Caroline and Engelhardt, Volker and Sadhasivam, Lingheswar and Einfalt, Tomaž and Ingelman-Sundberg, Magnus and van Riet, Sander},
  title = {A Long‐Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc ‐Conjugated siRNAs},
  journal = {Clinical and Translational Science},
  year = {2026},
  doi = {10.1111/cts.70536}
}
Kostenlos starten →